Geriatric Polypharmacy Interventions: How to Reduce Adverse Drug Events in Older Adults

More than 41% of adults over 65 in the U.S. take five or more medications daily. For many, this isn’t a choice-it’s the result of managing diabetes, heart disease, arthritis, and depression all at once. But each extra pill adds risk. Studies show that every additional medication increases the chance of a dangerous fall by about 8%. And with hospitalizations from drug reactions costing the U.S. healthcare system over $30 billion a year, it’s clear: we need better ways to manage what’s called geriatric polypharmacy.

What Exactly Is Geriatric Polypharmacy?

Polypharmacy isn’t just about taking a lot of pills. It’s when someone regularly uses five or more medications, especially when some of them don’t add real benefit-or even cause harm. The American Geriatrics Society and the American Academy of Family Physicians both use this five-pill threshold because research shows risks climb sharply after this point. It’s not the number alone, though. It’s the mix. A blood pressure drug, a sleep aid, an anticholinergic for overactive bladder, a painkiller, and a statin might seem fine on paper. But together, they can blur a patient’s thinking, weaken their balance, or drop their blood pressure too low.

Older adults are especially vulnerable. Their bodies process drugs differently. Kidneys slow down. Liver function declines. And many take meds prescribed by different doctors-each focused on one condition, not the whole picture. A 2023 study found that nearly 80% of seniors see five or more providers each year. No one is looking at the full list.

The Real Danger: Adverse Drug Events

Adverse drug events (ADEs) aren’t just side effects. They’re preventable harms: falls, confusion, kidney damage, internal bleeding, or sudden hospital trips. One landmark study in the Journal of the American Geriatrics Society found that seniors on four or more medications had a 30-50% higher risk of injurious falls. Each extra pill? Add another 8% risk.

And it’s not just falls. A 2022 report from the Institute for Safe Medication Practices showed that nearly 28% of all hospital admissions for older adults were linked to medication problems. That’s one in four. Many of these could be avoided.

Some medications are especially risky for seniors. The 2023 update to the Beers Criteria-a widely used guide for unsafe prescribing in older adults-added new red flags. Anticholinergics like diphenhydramine (Benadryl) can cause memory loss. Benzodiazepines like lorazepam increase fall risk. Even long-term proton pump inhibitors (PPIs) for heartburn can lead to bone fractures and infections. These aren’t rare cases. They’re common.

Three Levels of Intervention-Only One Works

Not all medication reviews are equal. Researchers have broken them down into three types:

• Type I: Just reviewing the medication list-no patient contact.
• Type II: Review plus checking if the patient is actually taking the pills.
• Type III: Full face-to-face (or video) consultation with a clinician who evaluates both the drugs and the patient’s health status.

Here’s the hard truth: only Type III works. A 2023 study in JAMA Network Open found that Type III interventions reduced unplanned hospital readmissions by 18.3%. Types I and II? No meaningful difference.

Why? Because you can’t fix polypharmacy from a chart. You need to talk to the person. Ask: Are you still taking this? Why? What are you worried about if you stop? One 82-year-old man was on seven medications, including a sleeping pill he hadn’t taken in two years. He didn’t know it was still on his list. Another woman was on a blood thinner she didn’t need anymore-her atrial fibrillation had resolved, but no one checked.

Tools That Actually Help

There are several clinical tools to guide decisions, but not all are equally useful.

• Beers Criteria (2023): Lists potentially inappropriate medications for older adults. Useful for flagging risks.
• STOPP/START v3 (2021): Identifies both inappropriate drugs (STOPP) and missed opportunities for needed drugs (START). This is the one that actually changes outcomes.
• FORTA List: Classifies drugs as Fit, Optimal, Recommended, or Avoided for older adults. Strong evidence for reducing harm.

Studies show that only STOPP/START and FORTA have proven to reduce hospitalizations and improve survival. Beers is helpful, but it doesn’t tell you when to start a needed drug-only what to avoid. That’s why many clinics now use both STOPP/START and FORTA together.

Who Should Lead These Interventions?

Pharmacists aren’t just pill counters. When they’re embedded in geriatric care teams under Collaborative Practice Agreements (CPAs), they cut inappropriate prescribing by over a third compared to doctors working alone. A 2025 study found pharmacist-led teams achieved 37.6% higher deprescribing rates.

But here’s the catch: only 22 U.S. states allow CPAs for pharmacists. In the rest, they can’t adjust prescriptions without a doctor’s signature-delaying care, frustrating patients, and wasting time.

And it’s not just pharmacists. The best results come from teams: a geriatrician, a clinical pharmacist, a nurse, and sometimes a social worker. They check for social barriers too. Is the patient struggling to afford meds? Can they open bottles? Do they have someone to help them take pills correctly?

Where It Goes Wrong

Many programs fail because they focus only on cutting pills-without checking if the patient needs them.

One study found that 12.8% of deprescribing attempts were inappropriate. Someone stopped a heart medication that was still needed. Another discontinued a thyroid pill, leading to fatigue and confusion. That’s why tools like STOPP/START and FORTA matter-they don’t just say “stop.” They say: Stop this, but consider starting that.

And then there’s the fear factor. A 2023 national poll found that 68.4% of older adults are scared to stop any medication-even ones they don’t take anymore. They worry about “going back” to how they felt before. That’s why communication is everything. You can’t just remove a pill. You have to explain why, how, and what to watch for.

Some patients even had bad experiences after rapid deprescribing. A 2022 JAMA Internal Medicine study found 12.4% of patients had withdrawal symptoms-seizures from stopping anticonvulsants too fast, or rebound anxiety from abruptly stopping benzodiazepines. Tapering matters. Monitoring matters.

What’s Working in Real Clinics

The Veterans Health Administration (VHA) has one of the most successful programs. Their Geriatric Research, Education and Clinical Centers (GRECCs) use embedded pharmacists who do full medication reviews every six months. They’ve reduced inappropriate prescribing by 26.8% in just three years.

Duke University’s “Five Tips” approach is simple: get the real list, use STOPP/START, involve the patient, taper slowly, and document everything. Their error rate dropped by over 40%.

Even small clinics are seeing results. One community health center in Oregon started using the Medication Appropriateness Index (MAI). Within a year, inappropriate prescribing fell by 31.2%. But they had to fight for time. Most primary care doctors have less than five minutes per patient to review meds. And only 15% of Medicare Advantage plans pay for these reviews.

The Future: AI and Personalized Risk Scores

In April 2024, Epic Systems launched its “Polypharmacy Risk Score”-an AI tool built into electronic health records. It analyzes a patient’s age, conditions, medications, lab results, and history of falls. In validation studies, it predicted adverse events with 87.3% accuracy.

The American Geriatrics Society is working on Beers Criteria v2026, which will include personalized deprescribing algorithms. And the National Institute on Aging is funding research into genomic risk scores-could your genes tell you if you’re more likely to have a bad reaction to a certain drug?

By 2030, experts predict comprehensive medication reviews will be standard for all older adults. Why? Because value-based care is here. Medicare is now penalizing providers whose patients have too many drugs. Starting in 2024, CMS includes polypharmacy metrics in its payment system. If more than 30% of your Medicare patients are on ten or more medications, your reimbursement drops.

What You Can Do

If you or a loved one is on five or more medications:

1. Get the full list-include supplements, OTCs, and creams.
2. Ask: “Which of these are still needed? Which might be causing problems?”
3. Request a full medication review with a pharmacist or geriatrician.
4. Never stop a drug suddenly. Ask about tapering.
5. Use STOPP/START or FORTA as a reference when talking to your provider.

It’s not about taking fewer pills. It’s about taking the right ones. For the right reasons. With the right support.